<DOC>
	<DOCNO>NCT02582177</DOCNO>
	<brief_summary>To evaluate superiority ketoconazole20mg/g betamethasone dipropionate 0.64 mg/g association ( Candicort® ) cream ointment versus clotrimazole 10mg dexamethasone acetate 0.443 mg/g association ( Baycuten N® ) cream , general relief sign symptom ( erythema , maceration , peeling , blister / papule / pustule , itch burn / sting ) 06 ( ± 1 ) day onset treatment .</brief_summary>
	<brief_title>Effectiveness Study Ketoconazole Betamethasone Treat Fungal Infection Dermatophytosis</brief_title>
	<detailed_description>Candicort® present formulation agent act etiological agent superficial mycosis , coverage dermatophytes frequent yeast ; inflammation generate infectious process prior , case secondary fungal infection wet potentially infected eczema fungal dermatitis ( atopic dermatitis , seborrhoeic dermatitis , intertrigo , dyshidrosis , contact dermatitis ) . The active ingredient ketoconazole betamethasone act , respectively , etiologic agent infection inflammation generate process , association show positive therapeutic response dermatitis confirm secondary infection potential yeast ( analysis carry association sulfate neomycin , aim cover bacterial infection together ) . 218 participant meet inclusion criterion classify exclusion criterion randomly allocate one two treatment group ( Candicort® Baycuten N® ) study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Ability understand consent participate clinical research , express signing Informed Consent Form ( ICF ) ; Participants moderate severe clinical diagnosis superficial mycoses , accord investigator assessment , cause Candida ssp follow fungal / dermatophytosis infection : Tinea corporis inflammatory ( except face ) , Tinea cruris Tinea inflammatory pedis , confirmation direct mycological examination ; Participant submit score great equal two erythema signal , check apply categorical scale four point ; Any observational finding ( clinical evaluation / physical ) interpret medical researcher risk research participant 's participation clinical trial ; Known hypersensitivity drug component use study ; Use prohibit drug last 90 day ; Immune impairment , accord investigator assessment ; Vulvovaginal candidiasis diagnostics , balanopreputial , nail , chronic mucocutaneous oral ; Diagnosis chickenpox , herpes simplex zoster , skin tuberculosis skin syphilis , systemic fungal infection ; Participants , though studied diagnosis fungal infection require systemic treatment accord severity injury accord opinion investigator ; Participants skin lesion clinical sign bacterial infection ; Participants treatment , opinion investigator , may affect result study ; Participants diagnose HIV ; Participants diagnose Diabetes Mellitus ; Women gestation period breastfeeding ; Female participant reproductive age agree use acceptable method contraception ( oral contraceptive , injectable contraceptive , intrauterine device ( IUD ) , hormonal implant , barrier method , hormonal patch tubal ligation ) ; except surgically sterile ( bilateral oophorectomy hysterectomy ) , menopausal least one year participant declare perform sexual practice reproductive way ; Participant participate clinical last twelve month , unless investigator considers may direct benefit thereof ; Participant kinship second degree bond employee employee Sponsor Research Center .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Fungal infection</keyword>
	<keyword>Skin infection</keyword>
	<keyword>Dermatophytoses</keyword>
</DOC>